Hormonal Contraceptives Market Trends and Overview

The market size of hormonal contraceptives was valued at USD 16.8 billion in 2022. It is projected to reach USD 23.89 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2023 to 2030.

Hormonal contraceptives play a crucial role in family planning and reproductive health. They are widely used by individuals seeking effective and convenient methods to prevent unwanted pregnancies. The market for these contraceptives has witnessed significant growth in recent years, driven by factors such as increasing awareness about family planning, rising population, and advancements in contraceptive technologies.

With the growing global population and the need for effective birth control methods, the demand for hormonal contraceptives is expected to continue its upward trajectory. These contraceptives offer various options, including oral pills, patches, injections, and implants, providing individuals with choices that suit their preferences and lifestyles.

Furthermore, the increasing prevalence of sexually transmitted infections (STIs) has also contributed to the demand for hormonal contraceptives. These contraceptives not only prevent pregnancies but also offer protection against certain STIs, making them a preferred choice for individuals seeking dual benefits.

Geographically, the market for hormonal contraceptives is witnessing significant growth in both developed and developing regions. North America and Europe have traditionally been the largest markets for these contraceptives, owing to high awareness levels and favorable government initiatives. However, emerging economies in Asia Pacific and Latin America are also witnessing rapid market growth, driven by increasing healthcare expenditure and rising awareness about reproductive health.

In conclusion, the hormonal contraceptives market is poised for substantial growth in the coming years. Factors such as increasing awareness, advancements in contraceptive technologies, and the need for effective family planning methods are driving the market's expansion. With a projected CAGR of 4.5% over the forecast period, the market is expected to reach USD 23.89 billion by 2030

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3063

KEY MARKET SEGMENTATION:

By Product

  • Transdermal Patches
  • Oral Contraceptive Pills
  • Emergency Contraceptive Pills
  • Injectable Birth Control
  • Vaginal Rings

By Hormones

  • Combined Hormonal Contraceptive
  • Progestin-Only Contraceptive

By Age Group

  • 14-23 Years
  • 24-35 Years
  • 36-45 Years
  • Above 45 Years

By End User

  • Household
  • Hospitals
  • Clinics

Some of the major key players are as follows:

Merck & Co., Inc., Teva Pharmaceuticals Industries Ltd, Bayer AG, Pfizer Inc., Agile Therapeutics, Cupid Ltd., Helm AG, Church & Dwight Co., Inc., Reckitt Benckiser Group PLC, Lupin Pharmaceuticals Inc. and others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com